Business

Anthropic sued over alleged theft of‘tens of thousands’ of songs

AI company faces multibillion dollar lawsuit over misuse of copyrighted songs to train Claude models

This story summarizes reporting from The Guardian. Read the original for full context. Wire items stay in our news sitemap for seven days. Editorial policy.

Read full story on The Guardian →

Dan Milmo Global technology editor31 Aug 2026, 12:42 pmUpdated 1d ago1 min readBusinessGlobal

Global — Dan Milmo Global technology editor

Anthropic sued over alleged theft of ‘tens of thousands’ of songs

AI company faces multibillion dollar lawsuit over misuse of copyrighted songs to train Claude models

All AI wants for Christmas is a vast back catalogue of songs without paying for it, according to a multibillion-dollar lawsuit against the startup behind the Claude chatbot.

Sony Music Publishing and Warner Chappell, music publishers who manage the copyright of songs on behalf of songwriters and composers, are seeking damages for alleged misuse of “tens of thousands” of copyrighted works by Anthropic.

All AI wants for Christmas is a vast back catalogue of songs without paying for it, according to a multibillion-dollar lawsuit against the startup behind the Claude chatbot.

This report is published with credit to The Guardian. The wire sent a summary; open the original for any extra context. Read on The Guardian →

Source: The Guardian · Dan Milmo Global technology editor. Published 31 Aug 2026, 12:42 pm.

Next news → Satsuki Katayama, the Woman at the Center …Browse more stories

Keep reading

Most relevant

Satsuki Katayama, the Woman at the Center of Japan’s Currency Fight

Japan’s finance minister, Satsuki Katayama, is under pressure to strengthen the yen while balancing competing demands from the prime minister and Washington.

Read on The New York Times →

Editor’s choice

Global bond rout deepens as oil prices jump; wheat prices highest since early 2023 – business live

European stock markets fall and Brent crude jumps above $92 a barrel amid renewed fighting in Middle East

Read on theguardian.com →

Also developing

Ozempic Maker Novo Nordisk’s Investors Are Nervously Looking Into the Future

Novo Nordisk’s chief executive, Mike Doustdar, is a year into a corporate turnaround. He says investors are still underestimating the promise of the company’s drugs.

Read on The New York Times →

Back to the desk

info@ebenezerdigital.com +91 98944 96560 WhatsApp